Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult

Abstract

Atrial septal defect (ASD) is second common congenital heart disease that often leads to adult period. Intracardiac or transesophageal echocardiography (TEE) is essential for percutaneous closure of ASD using Amplatzer septal occluder. Dexmedetomidine (DEX), which is a highly selective α2-agonist, has sedative and analgesic properties without respiratory depression in the clinical dose range. We report percutaneous closure of ASD with TEE under DEX sedation.

doi: http://dx.doi.org/10.12669/pjms.296.3616

How to cite this:Jung JW, Go GC, Jeon SY, Bang S, Lee KH, Kim YH, et al. Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult. Pak J Med Sci 2013;29(6):1456-1458.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.